Skip to content

Thyroid Function , HbA1c in Relation to Ferritin Level in Adullt Patient e B Thalassemia

Thyroid Function , HbA1c in Relation to Ferritin Level in Adullt Patient e B Thalassemia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06377865
Enrollment
72
Registered
2024-04-22
Start date
2024-05-01
Completion date
2026-05-01
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B Thalassemia

Brief summary

to evaluate thyroid function ,HbA1C,&lipid profile in thalassemic patient to correlate thyroid function , Hba1c , lipid profile e ferritin level in thalassemic patient

Detailed description

B-Thalassemia major (b-TM) is a hereditary ،anemia resulting from defects in the production of b-globin chains and is one of the most common genetic disorders worldwide. The clinical classification of thalassemias is currently widely applied in clinical practice related to transfusion requirements Transfusion-dependent thalassemia (TDT) is defined as a condition where patients cannot produce adequate hemoglobin to survive without blood transfusion. Non-transfusion-dependent thalassemia (NTDT) is a descriptive term for patients who do not require regular lifelong transfusions. They may require intermittent or frequent transfusions in certain clinical situations. Patients with β-thalassemia intermedia have symptoms in between carriers and those with β-thalassemia major. Endocrine complications are the commonest among BTM patients and the attributing factor is iron deposition in endocrine organs due to frequent blood transfusions along with suboptimal iron chelation. Thus, keeping an iron level within the useful and safe range is critical since a low amount can cause anemia, while a high level can cause tissue damage Background pathophysiologic mechanism leading to DM in TM is unclear; some regard the iron induced pancreas cytotoxicity as the most significant contributor, a new hypothesis suggests the exhaustion of beta pancreatic cells subsequent to a chronic period of hyperinsulinemia .There are 5% of thalassemia patients develop clinical hypothyroidism that requires treatment, a bigger number of them develop subclinical compensated hypothyroidism with normal T3 and T4 levels but high TSH serum levels. The TDT is also associated with altered lipid levels because of oxidative stress that can lead to early atherosclerosis, adding to the morbidity and even early mortality.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* patient aged18 and older * both gender * patient diagnosed B thalassemia major * patient diagnosed B thalassemia intermediate

Exclusion criteria

* thalaasemia trait * age less than 18 * type 1 D.M * pt known thyroid &recive tttt

Design outcomes

Primary

MeasureTime frameDescription
Thyroid function ,Hba1c in relation to ferritin level in adult patients with beta thalassemia24 monthHbA1c in thalassemia major versus intermediate

Contacts

Primary Contactdemiana AD aziz, researcher
nanaa3964@gmail.com01551633796
Backup ContactMaha Abdalaziz, Associate prof
maha.hemetolojy@aun.edu.eg01097278659

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026